European litigation : the CJEU rules on limitation periods and the reimbursement of subsidies

Seized of a complex dispute, the General Court of the European Union was asked to rule on a claim for the recovery of European subsidies granted to a research centre under a research and development programme.

The firm ELEA AVOCAT represented the research centre in this landmark case, illustrating the legal challenges related to the management of European funds, particularly regarding limitation periods, financial regularity, and contractual interpretation.

The origin of the dispute: financial irregularities identified by OLAF

Following an audit and an investigation by the European Anti-Fraud Office (OLAF), the European Commission issued, on 13 March 2009, four debit notes against the research centre.

These notes requested the reimbursement of the allocated funds, as well as default interest. The Commission also sought to have the research centre ordered to pay the costs.

The centre challenged this decision before the General Court of the European Union, raising, in particular, an objection of prescription.

The subject of the dispute

The dispute mainly concerned the limitation period applicable to the Commission’s action.

The centre argued that the contract in question was governed by Belgian law, in the absence of specific limitation provisions in the EU Financial Regulation applicable at the time.

According to Article 2257 of the Belgian Civil Code, the ten-year limitation period for personal actions runs from the day the claim becomes due.

Under the contractual clauses, the claim became due upon a prior request for reimbursement, made on 13 March 2009.

The interruption of the limitation period

However, the Commission argued that the limitation period had been interrupted twice by acts constituting acknowledgment of debt.

These interruptions extended the period during which the Commission could lawfully bring an action for recovery.

La décision du Tribunal de l'Union européenne

The Court upheld the Commission’s arguments, finding that:

• the claim was due in accordance with the contractual provisions;

• the limitation period had not expired, given the interruptions that occurred.

  
  

Consequently, the Court ruled the Commission’s action admissible and well-founded.

Legal implications and significance of the decision

This case highlights the strict control exercised by the European Commission over the use of funds, even several years after disbursement.

It also underlines the need for beneficiaries and managing authorities to secure financial agreements by anticipating issues related to limitation periods and fund traceability.

Ensuring sound legal and contractual management

Beyond the decision itself, this litigation illustrates the importance of a rigorous and preventive approach to managing European financing.

ELEA AVOCAT assists both beneficiaries of EU funds and public authorities in preventing legal risks, ensuring compliance of procedures, and, where necessary, resolving disputes before national or European courts.

The common objective remains clear: to ensure the compliant, transparent, and effective use of European subsidies, in support of scientific, economic, and regional development.